Literature DB >> 28461261

Potential and future scope of nanoemulgel formulation for topical delivery of lipophilic drugs.

Pinaki Sengupta1, Bappaditya Chatterjee2.   

Abstract

The Nanoemulgel drug delivery system is a formulation related intervention to improve the systemic delivery and therapeutic profile of lipophilic drugs. Nanoemulgel is an amalgamated formulation of two different systems in which nanoemulsion containing drug is incorporated into a gel base. The fusion of the two systems makes this formulation advantageous in several ways. Lipophilic drugs can be easily incorporated and the skin permeability of the incorporated drugs can be enhanced in several folds due to the finely distributed droplets of nanoemulsion phase. As a result, the pharmacokinetic and pharmacodynamic profiles of the lipophilic drugs are improved significantly. An increasing trend in topical nanoemulgel use in recent years has been noticed because of the better acceptability of the preparation to the patients due to their noninvasive delivery, avoidance of gastrointestinal side effects, easier applicability and good therapeutic and safety profile. Despite of having few limitations, nanoemulgel formulation can be considered as a potential and promising candidates for topical delivery of lipophilic drugs in the future. The aim of this review is to evaluate and report the current potential and future scope of nanoemulgel formulation for becoming an effective delivery system for poorly water soluble drugs. In this review, we have summarized and discussed the outcome of different studies on permeability, pharmacokinetic, pharmacodynamic and safety profile of the drugs delivered topically through nanoemulgel. Rationality of use along with the major challenges to overcome for nanoemulgel formulation has been discussed.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Lipophilic drugs; Nanoemulgel; Pharmacodynamics; Pharmacokinetics; Topical delivery

Mesh:

Substances:

Year:  2017        PMID: 28461261     DOI: 10.1016/j.ijpharm.2017.04.068

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  6 in total

1.  Nanoemulgel for Improved Topical Delivery of Desonide: Formulation Design and Characterization.

Authors:  Qiuyan Ma; Jing Zhang; Bohong Lu; Huaqing Lin; Rajib Sarkar; Tao Wu; Xuee Li
Journal:  AAPS PharmSciTech       Date:  2021-05-24       Impact factor: 3.246

2.  Formulation Strategies to Improve Nose-to-Brain Delivery of Donepezil.

Authors:  Lupe Carolina Espinoza; Marcelle Silva-Abreu; Beatriz Clares; María José Rodríguez-Lagunas; Lyda Halbaut; María-Alexandra Cañas; Ana Cristina Calpena
Journal:  Pharmaceutics       Date:  2019-02-01       Impact factor: 6.321

3.  Eprinomectin nanoemulgel for transdermal delivery against endoparasites and ectoparasites: preparation, in vitro and in vivo evaluation.

Authors:  Yujuan Mao; Xiaolan Chen; Bohui Xu; Yan Shen; Zixuan Ye; Birendra Chaurasiya; Li Liu; Yi Li; Xiaoling Xing; Daquan Chen
Journal:  Drug Deliv       Date:  2019-12       Impact factor: 6.419

4.  Resveratrol loaded glycyrrhizic acid-conjugated human serum albumin nanoparticles for tail vein injection II: pharmacokinetics, tissue distribution and bioavailability.

Authors:  Mingfang Wu; Chen Zhong; Yiping Deng; Qian Zhang; Xiaoxue Zhang; Xiuhua Zhao
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

5.  Nanoemulsion-based dissolving microneedle arrays for enhanced intradermal and transdermal delivery.

Authors:  Muhammad Iqbal Nasiri; Lalitkumar K Vora; Juhaina Abu Ershaid; Ke Peng; Ismaiel A Tekko; Ryan F Donnelly
Journal:  Drug Deliv Transl Res       Date:  2021-12-22       Impact factor: 4.617

6.  Novel Clove Essential Oil Nanoemulgel Tailored by Taguchi's Model and Scaffold-Based Nanofibers: Phytopharmaceuticals with Promising Potential as Cyclooxygenase-2 Inhibitors in External Inflammation.

Authors:  Reham Mokhtar Aman; Irhan Ibrahim Abu Hashim; Mahasen Mohamed Meshali
Journal:  Int J Nanomedicine       Date:  2020-03-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.